Paracrine Effect of Mesenchymal Stem Cells Derived from Human Adipose Tissue in Bone Regeneration

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2014 Sep 9

PMID 25198551

Citations 151

Authors

Itali Linero

Orlando Chaparro

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cell (MSC) transplantation has proved to be a promising strategy in cell therapy and regenerative medicine. Although their mechanism of action is not completely clear, it has been suggested that their therapeutic activity may be mediated by a paracrine effect. The main goal of this study was to evaluate by radiographic, morphometric and histological analysis the ability of mesenchymal stem cells derived from human adipose tissue (Ad-MSC) and their conditioned medium (CM), to repair surgical bone lesions using an in vivo model (rabbit mandibles). The results demonstrated that both, Ad-MSC and CM, induce bone regeneration in surgically created lesions in rabbit's jaws, suggesting that Ad-MSC improve the process of bone regeneration mainly by releasing paracrine factors. The evidence of the paracrine effect of MSC on bone regeneration has a major impact on regenerative medicine, and the use of their CM can address some issues and difficulties related to cell transplants. In particular, CM can be easily stored and transported, and is easier to handle by medical personnel during clinical procedures.

Citing Articles

Combined exosome of adipose-derived mesenchymal stem cell and hyaluronic acid delays early osteoarthritis progression of ovine sheep model: Clinical, radiographic, macroscopic and microscopic evaluation.

Powantia Pontoh L, Fiolin J, Dilogo I, Prasetyo M, Antarianto R, Harahap A F1000Res. 2025; 13:494.

PMID: 39989481 PMC: 11842963. DOI: 10.12688/f1000research.147309.2.

Unlocking the Therapeutic Potential of Adipose-Derived Stem Cell Secretome in Oral and Maxillofacial Medicine: A Composition-Based Perspective.

Giannasi C, Cadelano F, Della Morte E, Baserga C, Mazzucato C, Niada S Biology (Basel). 2025; 13(12.

PMID: 39765683 PMC: 11673083. DOI: 10.3390/biology13121016.

Dental Pulp Stem Cell Conditioned Medium Enhance Osteoblastic Differentiation and Bone Regeneration.

Chouaib B, Desoutter A, Cuisinier F, Collart-Dutilleul P Stem Cell Rev Rep. 2024; 21(2):477-490.

PMID: 39514179 DOI: 10.1007/s12015-024-10823-2.

The Role of Mitochondrial Homeostasis in Mesenchymal Stem Cell Therapy-Potential Implications in the Treatment of Osteogenesis Imperfecta.

Guo Q, Zhai Q, Ji P Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458939 PMC: 11510265. DOI: 10.3390/ph17101297.

iPSC-derived lung and lung cancer organoid model to evaluate cisplatin encapsulated autologous iPSC-derived mesenchymal stromal cell-isolated extracellular vesicles.

Kustermann C, Narbute K, Movcana V, Parfejevs V, Rumnieks F, Kaukis P Stem Cell Res Ther. 2024; 15(1):246.

PMID: 39113093 PMC: 11304910. DOI: 10.1186/s13287-024-03862-6.

References

Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Atashi A . Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report. J Craniomaxillofac Surg. 2011; 40(1):2-7. DOI: 10.1016/j.jcms.2011.02.003. View

Parekkadan B, van Poll D, Megeed Z, Kobayashi N, Tilles A, Berthiaume F . Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007; 363(2):247-52. PMC: 2096777. DOI: 10.1016/j.bbrc.2007.05.150. View

Ranganath S, Levy O, Inamdar M, Karp J . Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell. 2012; 10(3):244-58. PMC: 3294273. DOI: 10.1016/j.stem.2012.02.005. View

Gimble J, Katz A, Bunnell B . Adipose-derived stem cells for regenerative medicine. Circ Res. 2007; 100(9):1249-60. PMC: 5679280. DOI: 10.1161/01.RES.0000265074.83288.09. View

van Koppen A, Joles J, van Balkom B, Lim S, de Kleijn D, Giles R . Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One. 2012; 7(6):e38746. PMC: 3378606. DOI: 10.1371/journal.pone.0038746. View

Nauth A, Ristevski B, Li R, Schemitsch E . Growth factors and bone regeneration: how much bone can we expect?. Injury. 2011; 42(6):574-9. DOI: 10.1016/j.injury.2011.03.034. View

Schmitz J, Hollinger J . The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res. 1986; (205):299-308. View

Kotobuki N, Katsube Y, Katou Y, Tadokoro M, Hirose M, Ohgushi H . In vivo survival and osteogenic differentiation of allogeneic rat bone marrow mesenchymal stem cells (MSCs). Cell Transplant. 2008; 17(6):705-12. DOI: 10.3727/096368908786092793. View

Janicki P, Schmidmaier G . What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells. Injury. 2011; 42 Suppl 2:S77-81. DOI: 10.1016/j.injury.2011.06.014. View

10.

Cho Y, Song H, Bhang S, Lee S, Kang B, Lee J . Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res. 2012; 90(9):1794-802. DOI: 10.1002/jnr.23063. View

11.

Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan D . Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science. 1996; 271(5247):360-2. DOI: 10.1126/science.271.5247.360. View

12.

Linero I, Doncel A, Chaparro O . [Proliferation and osteogenic differentiation of mesenchymal stem cells in hydrogels of human blood plasma]. Biomedica. 2014; 34(1):67-78. DOI: 10.1590/S0120-41572014000100010. View

13.

Morad G, Kheiri L, Khojasteh A . Dental pulp stem cells for in vivo bone regeneration: a systematic review of literature. Arch Oral Biol. 2013; 58(12):1818-27. DOI: 10.1016/j.archoralbio.2013.08.011. View

14.

Stockmann P, Park J, von Wilmowsky C, Nkenke E, Felszeghy E, Dehner J . Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources. J Craniomaxillofac Surg. 2011; 40(4):310-20. DOI: 10.1016/j.jcms.2011.05.004. View

15.

Mirotsou M, Jayawardena T, Schmeckpeper J, Gnecchi M, Dzau V . Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol. 2010; 50(2):280-9. PMC: 3021634. DOI: 10.1016/j.yjmcc.2010.08.005. View

16.

Li F, Whyte N, Niyibizi C . Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration. Biochem Biophys Res Commun. 2012; 426(4):475-9. DOI: 10.1016/j.bbrc.2012.08.095. View

17.

Horie M, Choi H, Lee R, Reger R, Ylostalo J, Muneta T . Intra-articular injection of human mesenchymal stem cells (MSCs) promote rat meniscal regeneration by being activated to express Indian hedgehog that enhances expression of type II collagen. Osteoarthritis Cartilage. 2012; 20(10):1197-207. PMC: 3788634. DOI: 10.1016/j.joca.2012.06.002. View

18.

Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E . Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2002; 101(9):3722-9. DOI: 10.1182/blood-2002-07-2104. View

19.

Chatterjea A, Meijer G, van Blitterswijk C, de Boer J . Clinical application of human mesenchymal stromal cells for bone tissue engineering. Stem Cells Int. 2010; 2010:215625. PMC: 2989379. DOI: 10.4061/2010/215625. View

20.

Im G, Shin Y, Lee K . Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells?. Osteoarthritis Cartilage. 2005; 13(10):845-53. DOI: 10.1016/j.joca.2005.05.005. View